IP Verse

Cipla competitive analysis

Latest publications and patents of Cipla New

Explore the latest publications and patents granted to Cipla, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Cipla

EP3071272
Jan 9, 2019Inhaler DeviceRevoked
EP1646417
Dec 5, 2018Inhaler ApparatusRevoked
EP2704781
Jan 24, 2018A Dose CounterNo Opposition Filed Within Time Limit

Latest oppositions filed by Cipla

Explore patent oppositions filed by Cipla against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2962690
(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPEOct 16, 2019

Latest patents of Cipla opposed by its competitors

Explore Cipla's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3071272
Jan 9, 2019Inhaler Device1
EP1646417
Dec 5, 2018Inhaler Apparatus1

Latest PTAB cases involving Cipla

Discover the latest PTAB cases involving Cipla, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 29, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Cipla

IPR2025-00033Oct 28, 2024CIPLAGILEAD SCIENCESInstitution Denied
IPR2020-00371Jan 31, 2020GLAXOSMITHKLINE CONSUMER HEALTHCARECIPLAInstitution Denied
IPR2020-00370Jan 31, 2020GLAXOSMITHKLINE CONSUMER HEALTHCARECIPLAInstitution Denied
IPR2020-00369Jan 31, 2020GLAXOSMITHKLINE CONSUMER HEALTHCARECIPLAInstitution Denied
IPR2020-00368Jan 31, 2020GLAXOSMITHKLINE CONSUMER HEALTHCARECIPLAInstitution Denied
IPR2019-01446Aug 1, 2019NEVAKARCIPLATerminated
IPR2018-01021Jun 5, 2018CIPLAALCON RESEARCHTerminated-Settled
IPR2018-01020Jun 5, 2018CIPLAALCON RESEARCHTerminated-Settled
IPR2018-00164Nov 9, 2017CIPLAABRAXISBIOSCIENCESInstitution Denied
IPR2018-00163Nov 9, 2017CIPLAABRAXIS BIOSCIENCESInstitution Denied

Peer Comparison New

IP litigation analysis comparing Cipla with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
CIPLA1166Aggressive
ABRAXIS BIOSCIENCES - - - 3Non-Active
ALCON RESEARCH - 1418Defensive
GLAXOSMITHKLINE CONSUMER HEALTHCARE - - 4 - Highly Aggressive